Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
EJNMMI Research
Published in: EJNMMI Research 1/2011

Open Access 01-12-2011 | Preliminary research

Imaging the effect of receptor for advanced glycation endproducts on angiogenic response to hindlimb ischemia in diabetes

Authors: Yared Tekabe, Xiaoping Shen, Joane Luma, Drew Weisenberger, Shi Fang Yan, Roland Haubner, Ann Marie Schmidt, Lynne Johnson

Published in: EJNMMI Research | Issue 1/2011

Login to get access

Abstract

Background

Receptor for advanced glycation endproducts (RAGE) expression contributes to the impaired angiogenic response to limb ischemia in diabetes. The aim of this study was to detect the effect of increased expression of RAGE on the angiogenic response to limb ischemia in diabetes by targeting αvβ3 integrin with 99mTc-labeled Arg-Gly-Asp (RGD).

Methods

Male wild-type (WT) C57BL/6 mice were either made diabetic or left as control for 2 months when they underwent femoral artery ligation. Four groups were studied at days 3 to 7 after ligation: WT without diabetes (NDM) (n = 14), WT with diabetes (DM) (n = 14), RAGE-/- NDM (n = 16), and RAGE-/- DM (n = 14). Mice were injected with 99mTc-HYNIC-RGD and imaged. Count ratios for ischemic/non-ischemic limbs were measured. Muscle was stained for RAGE, αvβ3, and lectins.

Results

There was no difference in count ratio between RAGE-/- and WT NDM groups. Mean count ratio was lower for WT DM (1.38 ± 0.26) vs. WT NDM (1.91 ± 0.34) (P<0.001). Mean count ratio was lower for the RAGE-/- DM group than for RAGE-/- NDM group (1.75 ± 0.22 vs. 2.02 ± 0.29) (P<0.001) and higher than for the WT DM group (P<0.001). Immunohistopathology supported the scan findings.

Conclusions

In vivo imaging of αvβ3 integrin can detect the effect of RAGE on the angiogenic response to limb ischemia in diabetes.
Appendix
Available only for authorised users
Literature
1.
Ouriel K: Peripheral arterial disease. Lancet 2001, 358: 1257–1264. 10.1016/S0140-6736(01)06351-6PubMedCrossRef
2.
Currie CJ, Morgan CL, Peters JR: The epidemiology and cost of inpatient care for peripheral vascular disease, infection, neuropathy, and ulceration in diabetes. Diabetes Care 1998, 21: 42–48. 10.2337/diacare.21.1.42PubMedCrossRef
3.
Scholz D, Ziebeglhoeffer T, Helisch A, Wagner S, Friedrich C, Podzuweit T, Schaper W: Contribution of arteriogenesis and angiogenesis to post occlusive hindlimb perfusion in mice. J Mol Cell Cardiol 2002, 34: 775–787. 10.1006/jmcc.2002.2013PubMedCrossRef
4.
Shoji T, Koyama H, Morioka T, Tanaka S, Kizu A, Motoyama K, Mori K, Fukumoto S, Shioi A, Shimogaito N, Takeuchi M, Yamamoto Y, Yonekura H, Yamamoto H, Nishizawa Y: Receptor for advanced glygation endproducts is involved in imapaired angiogenic response in diabetes. Diabetes 2006, 55: 2245–2255. 10.2337/db05-1375PubMedCrossRef
5.
Tamarat R, Silvestre J-S, Huijberts M, Benessiano J, Ebrahimian TG, Duriez M, Wautier MP, Wautier JL, Lévy BI: Blockade of advanced glycation endproduct formation restores ischemia-induced angiogenesis in diabetic mice. Proc Natl Acad Sci 2003, 100: 8555–8560. 10.1073/pnas.1236929100PubMedCentralPubMedCrossRef
6.
Tchaikovski V, Olieslagers S, Bohmer FD, Waltenberger J: Diabetes mellitus activates signal transduction pathways resulting in vascular endothelial growth factor resistance of human monocytes. Circulation 2009, 120: 150–159. 10.1161/CIRCULATIONAHA.108.817528PubMedCrossRef
7.
Shen X, Song F, Rosario R, Morales A, Zou YS, Schmidt AM, Yan SF: Abstract 5757: RAGE in bone marrow derived cells blunts restoration of blood flow in mice subjected to femoral artery ligation. Circulation 2009, 120: S1142.
8.
Haubner R: α v β 3 -integrin imaging: a new approach to characterize angiogenesis? Eur J Nucl Med Mol Imaging 2006, 33: S54-S63. 10.1007/s00259-006-0136-0CrossRef
9.
Liliensiek B, Weigand MA, Bierhaus A, Nicklas W, Kasper M, Hofer S, Plachky J, Gröne HJ, Kurschus FC, Schmidt AM, Yan SD, Martin E, Schleicher E, Stern DM, Hämmerling GG, Nawroth PP, Arnold B: Receptor for advanced glycation endproducts (RAGE) regulates sepsis but not the adaptive immune response. J Clin Invest 2004, 113: 1641–1650.PubMedCentralPubMedCrossRef
10.
Roguin A, Nitecki S, Rubinstein I, Nevo E, Avivi A, Levy NS, Abassi ZA, Sabo E, Lache O, Frank M, Hoffman A, Levy AP: Vascular endothelial growth factor (VEGF) fails to improve blood flow and to promote collateralization in a diabetic mouse ischemic hindlimb model. Cardiovascular Diabetology 2003, 2: 1–6. 10.1186/1475-2840-2-1CrossRef
11.
Hazarika S, Dokun AO, Li Y, Popel AS, Kontos CD, Annex BH: Impaired angiogenesis after hindlimb ischemia in type 2 diabetes mellitus. Circ Res 2007, 101: 948–956. 10.1161/CIRCRESAHA.107.160630PubMedCrossRef
12.
Loomans CJ, de Koning EJ, Staal FJ, Rookmaaker MB, Verseyden C, de Boer HC, Verhaar MC, Braam B, Rabelink TJ, van Zonneveld AJ: Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes. Diabetes 2004, 53: 195–199.PubMedCrossRef
13.
Tepper OM, Galiano RD, Capla JM, Kalka C, Gagne PJ, Jacobowitz GR, Levine JP, Gurtner GC: Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 2002, 106: 2781–2786. 10.1161/01.CIR.0000039526.42991.93PubMedCrossRef
14.
Sneider EB, Nowicki PT, Messina LM: Regenerative medicine in the treatment of peripheral arterial disease. J Cell Biochem 2009, 108: 753–761. 10.1002/jcb.22315PubMedCrossRef
15.
Tsou R, Isik F: Integrin activation is required for VEGF and FGF receptor protein presence on human microvascular endothelial cells. Mol Cell Biochem 2001, 224: 81–89. 10.1023/A:1011947301849PubMedCrossRef
16.
Heil M, Clauss M, Suzuki K, Buschmann IR, Willuweit A, Fischer S, Schaper W: Vascular endothelial growth factor (VEGF) stimulates monocyte migration through endothelial monolayers via increased integrin expression. Eur J Cell Biol 2000, 79: 850–857. 10.1078/0171-9335-00113PubMedCrossRef
17.
Senger DR, Ledbetter SR, Claffey KP, Papadopoulos-Sergiou A, Perruzzi CA, Detmar M: Stimulation of endothelial cell migration by vascular permeability factor/vascular endothelial growth factor through cooperative mechanisms involving the α v β 3 integrin, osteopontin, and thrombin. Am J Pathol 1996, 149: 1.PubMedCentralPubMed
18.
Bayless KJ, Salazar R, Davis GE: RGD-dependent vacuolation and lumen formation observed during endothelial cell morphogenesis in three-dimensional fibrin matrices involves the α v β 3 and α v β 1 integrins. Am J Pathol 2000, 156: 1673–1683. 10.1016/S0002-9440(10)65038-9PubMedCentralPubMedCrossRef
19.
Haubner R, Wester HJ, Burkhart F, Senekowitsch-Schmidtke R, Weber W, Goodman SL, Kessler H, Schwaiger M: Glycosylate RGD-containing peptides: tracer for tumor targeting and angiogenesis imaging with improved biokinetics. J Nucl Med 2001, 42: 326–336.PubMed
20.
Decristoforo C, Faintuch-Linkowski B, Rey A, von Guggenberg E, Ruppricha M, Hernandez-Gonzales I, Rodrigo T, Haubner R: [ 99m Tc] HYNIC-RGD for imaging integrin α v β 3 expression. Nucl Med Biol 2006, 33: 945–952. 10.1016/j.nucmedbio.2006.09.001PubMedCrossRef
21.
Hua J, Dobrucki LW, Sadeghi MM, Zhang J, Bourke BN, Cavaliere P, Song J, Chow C, Jahanshad N, van Royen N, Buschmann I, Madri JA, Mendizabal M, Sinusas AJ: Noninvasive imaging of angiogenesis with a 99m Tc-labeled peptide targeted at α v β 3 integrin after murine hindlimb ischemia. Circulation 2005, 111: 3255–3260. 10.1161/CIRCULATIONAHA.104.485029PubMedCrossRef
22.
Meoli DF, Sadeghi MM, Krassilnikova S, Bourke BN, Giordano FJ, Dione DP, Su H, Edwards DS, Liu S, Harris TD, Madri JA, Zaret BL, Sinusas AJ: Noninvasive imaging of myocardial angiogenesis following experimental myocardial infarction. J Clin Invest 2004, 113: 1684–1691.PubMedCentralPubMedCrossRef
23.
Johnson LL, Schofield L, Donahay T, Bouchard M, Poppas A, Haubner R: Radiolabeled arginine-glycine-aspartic acid peptides to image angiogenesis in swine model of hibernating myocardium. J Am Coll Cardiol Img 2008, 1: 500–510.CrossRef
Metadata
Title
Imaging the effect of receptor for advanced glycation endproducts on angiogenic response to hindlimb ischemia in diabetes
Authors
Yared Tekabe
Xiaoping Shen
Joane Luma
Drew Weisenberger
Shi Fang Yan
Roland Haubner
Ann Marie Schmidt
Lynne Johnson
Publication date
01-12-2011
Publisher
Springer Berlin Heidelberg
Published in
EJNMMI Research / Issue 1/2011
Electronic ISSN: 2191-219X
DOI
https://doi.org/10.1186/2191-219X-1-3

Other articles of this Issue 1/2011

EJNMMI Research 1/2011 Go to the issue

Preliminary research

P-glycoprotein at the blood-brain barrier: kinetic modeling of 11C-desmethylloperamide in mice using a 18F-FDG μPET scan to determine the input function

Original research

Brain perfusion CT compared with15O-H2O-PET in healthy subjects

Original research

Decreased defluorination using the novel beta-cell imaging agent [18F]FE-DTBZ-d4 in pigs examined by PET

Original research

Evaluation of 18F-nifene binding to α4β2 nicotinic receptors in the rat brain using microPET imaging

Original research

Mini-PEG spacering of VAP-1-targeting 68Ga-DOTAVAP-P1 peptide improves PET imaging of inflammation

Preliminary research

18F-fluoride PET: changes in uptake as a method to assess response in bone metastases from castrate-resistant prostate cancer patients treated with 223Ra-chloride (Alpharadin)